首页> 外文会议>International symposium on controlled release of bioactive materials >An in situ forming polymeric gel for macromolecular drugs
【24h】

An in situ forming polymeric gel for macromolecular drugs

机译:用于大分子药物的原位形成聚合物凝胶

获取原文

摘要

The clinical use of macromolecular drugs is limited by the lack of effective drug-delivery methods that can protect and release them in a pro-active or an active form. This study describes the development and characterization of the in vitro and in vivo properties of an in situ forming polymeric gel for the delivery of phophorothioate oligonucleotides (psODNs). The formation of a polymeric gel in situ, from an ethanol-water cosolvent system has been demonstrated previously. Currently, it is hypothesized that an insoluble interpolymeric complex of biocompatible polymers, poly(methacrylic acid), 15,000 kDa, and poly(ethylene glycol), 20,000 kDa, will yield a clear solution in a biocompatible solvent system and transform into a gel at physiological pH. The gel will protect the entrapped macromolecular drug(s) and dissolve slowly to sustain the release of macromolecules over a period of time.
机译:大分子药物的临床用途受缺乏有效的药物递送方法,可在主活性或活性形式中保护和释放它们。该研究描述了在体外的体外和体内性质的开发和表征,其原位形成聚合物凝胶用于递送酚磷酸寡核苷酸(Psodns)。从前说明了从乙醇 - 水助理系统中形成的聚合物凝胶。目前,假设生物相容性聚合物,聚(甲基丙烯酸),15,000kDa和聚(乙二醇),20,000kDa的不溶性互聚物复合物将在生物相容性溶剂系统中产生澄清溶液,并在生理的凝胶中转化为凝胶pH。凝胶将保护捕获的大分子药物并缓慢溶解,以在一段时间内维持大分子的释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号